Literature DB >> 30263633

Oligochitosan as a potential anti-acne vulgaris agent: combined antibacterial effects against Propionibacterium acnes.

Song-Hee Kim1, Sung-Hwan Eom2, Daeung Yu3, Myung-Suk Lee4, Young-Mog Kim1,5.   

Abstract

To develop an antibacterial treatment for acne vulgaris using natural substance with few side effects, we investigated the antibacterial activities of oligochitosan against acne-related bacteria, particularly Propionibacterium acnes. Oligochitosan showed potent antibacterial effect on P. acnes. Especially, 10 kDa oligochitosan presented the highest antimicrobial effect with minimum inhibitory concentration values of 32-64 μg/mL on P. acnes. In addition, oligochitosan clearly reversed the antibacterial effect of tetracycline and erythromycin on P. acnes in the combination mode. The combination of tetracycline- or erythromycine-10 kDa oligochitosan resulted in a median ΣFIC range of 0.02-0.56, suggesting that the antibiotics-oligochitosan combination resulted in an antibacterial synergy against P. acnes. Thus, the results obtained in this research strongly supported that erythromycin and tetracycline will restore the antibacterial activity against P. acnes in the combination mode with 10 kDa oligochitosan.

Entities:  

Keywords:  Acne-related bacteria; Antibacterial activity; Erythromycin; Oligochitosan; Synergistic effect; Tetracycline

Year:  2017        PMID: 30263633      PMCID: PMC6049561          DOI: 10.1007/s10068-017-0118-y

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  18 in total

Review 1.  Chitosan as antimicrobial agent: applications and mode of action.

Authors:  Entsar I Rabea; Mohamed E-T Badawy; Christian V Stevens; Guy Smagghe; Walter Steurbaut
Journal:  Biomacromolecules       Date:  2003 Nov-Dec       Impact factor: 6.988

Review 2.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

3.  Simultaneous depolymerization and decolorization of chitosan by ozone treatment.

Authors:  S Seo; J M King; W Prinyawiwatkul
Journal:  J Food Sci       Date:  2007-11       Impact factor: 3.167

4.  In vitro evaluation of calcium binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core-shell nanoparticles.

Authors:  I Bravo-Osuna; G Millotti; C Vauthier; G Ponchel
Journal:  Int J Pharm       Date:  2007-02-03       Impact factor: 5.875

5.  Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus.

Authors:  Peter Eaton; João C Fernandes; Eulália Pereira; Manuela E Pintado; F Xavier Malcata
Journal:  Ultramicroscopy       Date:  2008-05-07       Impact factor: 2.689

6.  Synergy assessed by checkerboard. A critical analysis.

Authors:  M H Hsieh; C M Yu; V L Yu; J W Chow
Journal:  Diagn Microbiol Infect Dis       Date:  1993 May-Jun       Impact factor: 2.803

7.  Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. The Comité de l'Antibiogramme de la Société Française de Microbiologie.

Authors:  C J Soussy; R Cluzel; P Courvalin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

8.  Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris.

Authors:  Pei-Feng Liu; Teruaki Nakatsuji; Wenhong Zhu; Richard L Gallo; Chun-Ming Huang
Journal:  Vaccine       Date:  2011-02-26       Impact factor: 3.641

9.  Antibacterial activity of some indigenous plants used for the treatment of wounds in the Eastern Cape, South Africa.

Authors:  D S Grierson; A J Afolayan
Journal:  J Ethnopharmacol       Date:  1999-07       Impact factor: 4.360

10.  Chitosan against cutaneous pathogens.

Authors:  Jackson Champer; Julie Patel; Nathalie Fernando; Elaheh Salehi; Victoria Wong; Jenny Kim
Journal:  AMB Express       Date:  2013-07-06       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.